Human Serum Laboratories manufactures the fgf9 human serum reagents distributed by Genprice. The Fgf9 Human Serum reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Human Serum. Other Fgf9 products are available in stock. Specificity: Fgf9 Category: Human Group: Serum
Human Serum Albumin |
Fitzgerald |
10 mg |
EUR 581 |
|
Description: Purified native Human Serum Albumin |
Human Serum Albumin |
Fitzgerald |
10 mg |
EUR 231 |
|
Description: Purified native Human Serum Albumin |
Serum information
Recombinant Human FGF9 |
PH2045-.1 |
ApexBio |
10X10ug |
EUR 688 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human FGF9 |
Z100215 |
ABM |
20 µg |
EUR 235 |
Description: FGF-9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. FGF-9 induces osteoblast proliferation and new bone formation in a bone organ assay. FGF-9 is produced by many prostate cancer cells and contributes to prostate cancer-induced new bone formation. It also may participate in the osteoblastic progression of prostate cancer in bone. It is also an autocrine and/or paracrine neurotrophic factor that promotes the survival of motoneurons and upregulates choline acetyl-transferase activity. FGF-9 enhances survival of AChE-positive neurons and increases their mean soma size. It also up-regulates their choline acetyltransferase activity as potently as NGF and the effect is greater than that elicited by bFGF, CNTF, or GDNF. FGF-9 acts as a survival factor for neurons but does not promote neurite outgrowth. FGF-9 has been shown to mediate its effects by binding to FGF receptors. It efficiently activates the FGFR2c splice form of FGFR2 and the FGFR3b and FGFR3c splice isoforms of FGFR3. |
Recombinant Human FGF9 |
Z100219 |
ABM |
1.0 mg |
EUR 5100 |
Description: FGF-9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. FGF-9 induces osteoblast proliferation and new bone formation in a bone organ assay. FGF-9 is produced by many prostate cancer cells and contributes to prostate cancer-induced new bone formation. It also may participate in the osteoblastic progression of prostate cancer in bone. It is also an autocrine and/or paracrine neurotrophic factor that promotes the survival of motoneurons and upregulates choline acetyl-transferase activity. FGF-9 enhances survival of AChE-positive neurons and increases their mean soma size. It also up-regulates their choline acetyltransferase activity as potently as NGF and the effect is greater than that elicited by bFGF, CNTF, or GDNF. FGF-9 acts as a survival factor for neurons but does not promote neurite outgrowth. FGF-9 has been shown to mediate its effects by binding to FGF receptors. It efficiently activates the FGFR2c splice form of FGFR2 and the FGFR3b and FGFR3c splice isoforms of FGFR3. |
Human Serum AB |
abx810549-10nmol |
Abbexa |
10 nmol |
Ask for price |
Human Serum AB |
abx810549-5nmol |
Abbexa |
5 nmol |
EUR 1075 |
Human Serum AB |
abx810550-10nmol |
Abbexa |
10 nmol |
Ask for price |
Human Serum AB |
abx810550-5nmol |
Abbexa |
5 nmol |
EUR 1100 |
Human Serum AB |
abx810551-10nmol |
Abbexa |
10 nmol |
Ask for price |
Human Serum AB |
abx810551-5nmol |
Abbexa |
5 nmol |
EUR 1212.5 |
Human Serum AB |
abx810552-10nmol |
Abbexa |
10 nmol |
Ask for price |
Human Serum AB |
abx810552-5nmol |
Abbexa |
5 nmol |
EUR 1550 |
Human Serum AB |
SC00B14 |
Neuromics |
100 ml |
EUR 434.4 |
Normal Human Serum |
90R-1002 |
Fitzgerald |
10 ml |
EUR 237 |
|
Description: Normal Human Serum which has been lipid extracted and dialyzed against 10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
Normal Human Serum |
MBS686120-2mL |
MyBiosource |
2mL |
EUR 150 |
Normal Human Serum |
MBS686120-5x2mL |
MyBiosource |
5x2mL |
EUR 515 |